Polycystic Ovary Syndrome (PCOS) Treatment Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-


Market Overview:

Polycystic ovary syndrome (PCOS) impacts approximately 5 to 10 million women in the United States. Symptoms are due to high androgen levels and include irregular menstrual cycles, excess hair growth, acne, and obesity. Diagnosis involves imaging tests and blood work looking at hormone levels and ovarian morphology. Treatment focuses on managing symptoms and may involve lifestyle changes, oral contraceptives, anti-androgens or insulin-sensitizing agents.

The global Polycystic Ovary Syndrome (PCOS) Treatment Market is estimated to be valued at US$ 1,086.6 Mn in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. 

Market key trends:

One of the key trends in the global PCOS treatment market is rising awareness through patient education initiatives by industry players. For instance, various programs spread awareness on early diagnosis and management of symptoms. Also, increasing adoption of insulin-sensitizing agents like metformin for improved glucose tolerance and weight management in PCOS patients is expected to support market growth over the forecast period. In addition, ongoing research for development of new drug molecules and treatment modalities is anticipated to present lucrative opportunities. Further, growth in disposable income in developing regions is expected to boost market expansion from 2023 to 2030.

Segment Analysis

The global polycystic ovary syndrome (PCOS) treatment market is segmented based on drug class, end user, and distribution channel. Based on drug class, the market is segmented into oral contraceptives, insulin-sensitizing agents, anti-depressants, diuretics, and oral nutritional supplements. The oral contraceptives segment currently dominates the market due to higher adoption of birth control pills to manage menstrual cycle irregularities and reduce risk of endometrial cancer in PCOS patients. 

Get more insights on this topic: https://www.coherentmarketinsights.com/market-insight/polycystic-ovarian-syndrome-treatment-market-1589

Key Takeaways

The global polycystic ovary syndrome (PCOS) treatment market is expected to witness high growth, exhibiting a CAGR of 4.8% over the forecast period, due to increasing awareness about disease management and treatment options. 

Regional analysis

North America currently dominates the global PCOS treatment market. This is attributed to the rising prevalence of PCOS, advanced healthcare infrastructure, and higher adoption of prescribed medications in the region. Asia Pacific is expected to witness the fastest growth during the forecast period owing to growing medical tourism industry, rising healthcare expenditure, and increasing focus of key players in developing countries.

Key players 

Key players operating in the polycystic ovary syndrome (PCOS) treatment market are Sanofi S.A., Amneal Pharmaceuticals, Inc., Laurus Labs Limited, Zydus Pharmaceuticals, Inc., Prasco Laboratories, Dr. Reddy's Laboratories, Cadila Pharmaceuticals, Novartis International AG, Concordia Pharmaceuticals Inc., Covis Pharmaceuticals, Inc., Cardinal Health, Aphena Pharma Solutions Tennessee, Inc., Mylan N.V., Evotec SE, McKesson Corporation, Teva Pharmaceutical Industries Ltd, Lupin Pharmaceutical and Sun Pharmaceutical Industries Ltd., Bayer AG.

Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-...
Read more

The Where and the How: Unraveling Biology's Spatial Enigma with Omics

-
Image
In the fast-evolving landscape of biomedical research, a revolutionary technique has emerged that promises to unlock new dimensions of understanding within cellular landscapes – Spatial Omics. This cutting-edge approach combines the power of genomics, transcriptomics, proteomics, and more, with spatial information, creating a holistic view of biological systems. At its core, Spatial Omics involves mapping the molecular composition of tissues with spatial context. Traditional omics techniques provide valuable insights into the molecules present in a sample, but they lack the crucial information about where these molecules are located within the tissue. Spatial Omics bridges this gap by preserving the spatial architecture, offering unprecedented insights into cellular interactions, organization, and function. Read More @   https://www.digitaljournal.com/pr/news/coherent-market-insights/spatial-omics-market-revenue-growth-rate-customer-needs-trend-manufacturers-and-forecast-to-2030-10...
Read more

Fertility And Pregnancy Rapid Test Kits Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-
Image
The global Fertility And Pregnancy Rapid Test Kits Market is estimated to be valued at US$ 1,451.9 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.  Market Overview:  Pregnancy Rapid Test kits help in early detection of pregnancy in women. They are easy-to-usekits providing quick results within 5-10 minutes without laboratory or medical assistance.  Market key trends:  One of the key trends driving growth in the fertility and pregnancy rapid test kits market is increasing demand for home use pregnancy and ovulation prediction test kits. Manufacturers are focusing on making test kits more affordable and convenient for home use without medical supervision. Portable personal fertility monitors that track various fertility signs like cervical mucus, basal body temperature, etc on a mobile app are gaining popularity. The increasing use of digital technology in ...
Read more